C134
AXP000085.1 · Oncolytic virus
- Platform
- HSV-1 (chimeric, gamma34.5-deleted with HCMV IRS1)
- Originator
- University of Alabama at Birmingham
- Sponsor
- University of Alabama at Birmingham
Names
| Name | Type | Source |
|---|---|---|
| C134 ambiguous | preferred name, code | curator, ncit |
Virus
- Role
- Oncolytic
- Family
- Orthoherpesviridae
- Virus
- herpes simplex virus 1 (NCBI Taxonomy 10298)
- Strain
- F
- Replication
- conditionally replicating
- Modifications
- both copies of gamma34.5 deleted; human cytomegalovirus IRS1 gene inserted
- Transgenes
- HCMV IRS1
- Route
- intratumoral, intracerebral
- Source
- evidence
Cross-references
- NCI Thesaurus
- C162635
Approvals
No regulatory approval recorded.
Clinical trials (3)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT06614855 | A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma | Active not recruiting | Phase 1 | 2025-06-02 | 2027-01-01 | 12 | Astrocytoma; Astrocytoma, Grade III; Astrocytoma, Grade IV; Glioblastoma; Glioblastoma (GBM); Gliosarcoma of Brain; Gliosarcoma, Adult |
| NCT06193174 | Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1) | Terminated | Phase 1 | 2024-06-21 | 2025-03-07 | 1 | Anaplastic Astrocytoma of Brain; Glioblastoma Multiforme of Brain; Gliosarcoma of Brain; Recurrent Malignant Glioma |
| NCT03657576 | Trial of C134 in Patients With Recurrent GBM | Completed | Phase 1 | 2019-09-23 | 2024-10-25 | 19 | Anaplastic Astrocytoma of Brain; Glioblastoma Multiforme of Brain; Gliosarcoma of Brain |
Unconfirmed matches (1)
Trials that mention one of the names in a weaker way (a code only in the title, a short or ambiguous name). Not counted above.
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions | Matched by |
|---|---|---|---|---|---|---|---|---|
| NCT00828789 | VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer | Completed | Phase 1 | 2009-02 | 2009-04 | 20 | AIDS; HCV; HIV; Hepatitis C | name in title: C134 |
Recent changes
No changes recorded in its trials yet.
Clinical papers
No confirmed clinical papers yet.
Unconfirmed matches (2)
Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 29937308 | Disparate genomic characteristics of concurrent endometrial adenocarcinoma and ovarian granulosa cell tumor, revealed by targeted next-generation sequencing. | Pathology, research and practice | 2018 | name in abstract: C134 |
| PMID 20384396 | Pharmacokinetics of multiple-dose darunavir in combination with low-dose ritonavir in individuals with mild-to-moderate hepatic impairment. | Clinical pharmacokinetics | 2010 | name in abstract: C134 |
Other papers
Preclinical studies, reviews and other papers that name it.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 28345027 | Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates. | Molecular therapy oncolytics | 2017 | name in title: C134 |
Unconfirmed matches (33)
Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 41646370 | A Minimal Model Framework for Robust CAR-T Cell and Oncolytic Virus Combination Therapy. | Research square | 2026 | name in abstract: C134 |
| PMID 42200614 | The Hungate1000 prokaryotic culture collection encodes a wide variety of bacteriocins. | mSystems | 2026 | name in abstract: C134 |
| PMID 39895691 | Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma. | Molecular therapy. Oncology | 2025 | name in abstract: C134 |
| PMID 41130984 | Zoonotic potential of methicillin-resistant Staphylococcus aureus isolated from pets and their owners in Bangladesh. | Scientific reports | 2025 | name in abstract: C134 |
| PMID 37255476 | FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology. | International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists | 2024 | name in abstract: C134 |
| PMID 38806994 | A viral attack on brain tumors: the potential of oncolytic virus therapy. | Journal of neurovirology | 2024 | name in abstract: C134 |
| PMID 37583388 | Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolution. | Molecular therapy oncolytics | 2023 | name in abstract: C134 |
| PMID 34004331 | Oncolytic viruses as a promising therapeutic strategy against the detrimental health impacts of air pollution: The case of glioblastoma multiforme. | Seminars in cancer biology | 2022 | name in abstract: C134 |
| PMID 35149441 | Substandard starch grain4 may function in amyloplast development by influencing starch and lipid metabolism in rice endosperm. | Journal of plant physiology | 2022 | name in abstract: C134 |
| PMID 32780225 | Identification of a Growth-Associated Single Nucleotide Polymorphism (SNP) in Cyclin C of the Giant Tiger Shrimp Penaeus monodon. | Biochemical genetics | 2021 | name in abstract: C134 |
| PMID 34502443 | Novel Lytic Enzyme of Prophage Origin from Clostridium botulinum E3 Strain Alaska E43 with Bactericidal Activity against Clostridial Cells. | International journal of molecular sciences | 2021 | name in abstract: C134 |
| PMID 32277291 | Directed evolution of a transcription factor PbrR to improve lead selectivity and reduce zinc interference through dual selection. | AMB Express | 2020 | name in abstract: C134 |
| PMID 30732290 | Deep neural networks assisted BOTDA for simultaneous temperature and strain measurement with enhanced accuracy. | Optics express | 2019 | name in abstract: C134 |
| PMID 30941116 | CAEV Vif Hijacks ElonginB/C, CYPA and Cullin5 to Assemble the E3 Ubiquitin Ligase Complex Stepwise to Degrade oaA3Z2-Z3. | Frontiers in microbiology | 2019 | name in abstract: C134 |
| PMID 31220629 | Structure elucidation and gene cluster characterization of the O-antigen of Yersinia kristensenii С-134. | Carbohydrate research | 2019 | name in abstract: C134 |
| PMID 31530674 | Structure-Function Studies of the Bacillus subtilis Ric Proteins Identify the Fe-S Cluster-Ligating Residues and Their Roles in Development and RNA Processing. | mBio | 2019 | name in abstract: C134 |
| PMID 29216507 | Chimeric HCMV/HSV-1 and Δγ134.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memory. | Translational oncology | 2018 | name in abstract: C134 |
| PMID 29477597 | N1-Nonyl-1,4-diaminobutane ameliorates brain infarction size in photochemically induced thrombosis model mice. | Neuroscience letters | 2018 | name in abstract: C134 |
| PMID 30052299 | Cysteine residues contribute to the dimerization and enzymatic activity of human nuclear dUTP nucleotidohydrolase (nDut). | Protein science : a publication of the Protein Society | 2018 | name in abstract: C134 |
| PMID 27560944 | Regulation of Organic Hydroperoxide Stress Response by Two OhrR Homologs in Pseudomonas aeruginosa. | PloS one | 2016 | name in abstract: C134 |
| PMID 25809915 | The N-terminal domain of Npro of classical swine fever virus determines its stability and regulates type I IFN production. | The Journal of general virology | 2015 | name in abstract: C134 |
| PMID 25119379 | Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines. | Gene therapy | 2014 | name in abstract: C134 |
| PMID 22227391 | Conformational dynamics of a membrane transport protein probed by H/D exchange and covalent labeling: the glycerol facilitator. | Journal of molecular biology | 2012 | name in abstract: C134 |
| PMID 19341824 | Cysteine residues of Carnation Italian Ringspot virus p19 suppressor of RNA silencing maintain global structural integrity and stability for siRNA binding. | Biochimica et biophysica acta | 2009 | name in abstract: C134 |
| PMID 17301275 | Novel human rotavirus of genotype G5P[6] identified in a stool specimen from a Chinese girl with diarrhea. | Journal of clinical microbiology | 2007 | name in abstract: C134 |
| PMID 17429445 | Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic viruses. | Gene therapy | 2007 | name in abstract: C134 |
| PMID 16233921 | Characterization of the neutralizing activity of three anti-human TNF monoclonal antibodies and prediction of their TNF epitopes by molecular modeling and mutant protein approach. | Immunology letters | 2006 | name in abstract: C134 |
| PMID 16776476 | Production of a monoclonal anti-myostatin antibody and the effects of in ovo administration of the antibody on posthatch broiler growth and muscle mass. | Poultry science | 2006 | name in abstract: C134 |
| PMID 15651731 | Analysis of cartilage oligomeric matrix protein (COMP) degradation and synthesis in equine joint disease. | Equine veterinary journal | 2005 | name in abstract: C134 |
| PMID 1659211 | Effects of pHi on Na(+)-H+, Na(+)-dependent, and Na(+)-independent C1(-)-HCO3-exchangers in vascular smooth muscle. | The American journal of physiology | 1991 | name in abstract: C134 |
| PMID 1809297 | [Biological and HPLC analysis of heparin after thermal treatment]. | Bollettino chimico farmaceutico | 1991 | name in abstract: C134 |
| PMID 2157739 | Porcine rotaviruses antigenically related to human rotavirus serotypes 1 and 2. | Journal of clinical microbiology | 1990 | name in abstract: C134 |
| PMID 6345395 | Cytotoxic effect of an alpha-hemolytic Escherichia coli strain on human blood monocytes and granulocytes in vitro. | Infection and immunity | 1983 | name in abstract: C134 |
NIH grants
| Project | Title | Organisation | PI | Years | Linked by |
|---|---|---|---|---|---|
| R01CA222903 | Oncolytic Immunotherapy using Chimeric HSV C134: A Phase I Trial and Establishment of Response Indicators in Recurrent Glioma Patients | UNIVERSITY OF ALABAMA AT BIRMINGHAM | MARKERT, JAMES M | 2018–2020 | name in title: C134 |
Notes
Second-generation gamma34.5-deleted oHSV in which the human cytomegalovirus IRS1 gene restores late protein synthesis in tumour cells. Phase 1 in recurrent glioma (NCT03657576).
How to cite
C134 (AXP000085.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000085.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.